These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27667270)

  • 1. [Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension].
    Deng YJ; Zhang SL; Liu PM; Mai LF; Tang JY; Yan L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):743-749. PubMed ID: 27667270
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism.
    Zhang SL; Gao JW; Guo Y; Feng QL; Tang JY; Yan L; Wang JF; Cheng H; Liu PM
    Front Endocrinol (Lausanne); 2020; 11():547356. PubMed ID: 33101195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biomarkers of endothelial dysfunction and risk of early organ damage: a comparison between patients with primary aldosteronism and essential hypertension].
    Liu G; Zhang SL; Liu PM; Yin GS; Tang JY; Ma DJ; Yan L; Wang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug; 40(8):640-4. PubMed ID: 23141006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
    Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible association between primary aldosteronism and a lower beta-cell function.
    Mosso LM; Carvajal CA; Maiz A; Ortiz EH; Castillo CR; Artigas RA; Fardella CE
    J Hypertens; 2007 Oct; 25(10):2125-30. PubMed ID: 17885557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study.
    Huang X; Yu S; Xiao H; Pei L; Chen Y; Chen W; Li Y; Xiao H; Cao X
    Int J Endocrinol; 2021; 2021():6685469. PubMed ID: 34194493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Profiles in Primary Aldosteronism Compared with Essential Hypertension: Propensity-Score Matching Study.
    Moon SJ; Jang HN; Kim JH; Moon MK
    Endocrinol Metab (Seoul); 2021 Aug; 36(4):885-894. PubMed ID: 34372626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
    Turchi F; Ronconi V; di Tizio V; Ceccoli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of metabolic disorders in patients with essential hypertension and patients with primary aldosteronism].
    Gong YC; Guo RM; Chen SX; Chu SL; Guo JZ; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Feb; 36(2):128-31. PubMed ID: 19099949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between uric acid and cardiovascular risk variables in a non-hospitalized population.
    Barbosa MC; Brandão AA; Pozzan R; Magalhães ME; Campana EM; Fonseca FL; Pizzi OL; Freitas EV; Brandão AP
    Arq Bras Cardiol; 2011 Mar; 96(3):212-8. PubMed ID: 21271175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokines and cardiometabolic profile in primary hyperaldosteronism.
    Iacobellis G; Petramala L; Cotesta D; Pergolini M; Zinnamosca L; Cianci R; De Toma G; Sciomer S; Letizia C
    J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension.
    Turchi F; Ronconi V; di Tizio V; Boscaro M; Giacchetti G
    Am J Hypertens; 2011 Dec; 24(12):1274-9. PubMed ID: 21850059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism.
    Mulatero P; Monticone S; Bertello C; Viola A; Tizzani D; Iannaccone A; Crudo V; Burrello J; Milan A; Rabbia F; Veglio F
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4826-33. PubMed ID: 24057288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of primary aldosteronism in newly diagnosed diabetes mellitus with hypertensive patients.
    Hu Y; Liu W; Zhang J; Su X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):923-928. PubMed ID: 33053533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.
    Savard S; Amar L; Plouin PF; Steichen O
    Hypertension; 2013 Aug; 62(2):331-6. PubMed ID: 23753408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central diastolic blood pressure, plasma aldosterone and uric acid are associated with microalbuminuria in essential hypertension: a case-control study.
    Li J; Yang N; Chou H; Shi L; Wei M; Li Y
    BMC Cardiovasc Disord; 2023 Oct; 23(1):511. PubMed ID: 37848834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.